In patients with ACLF, immune paralysis is a critical aspect of the pathogenic mechanism, and the primary immune cells in the liver are KCs; therefore, we used the KC cell surface marker CD68 to costain with Gal-9 (Fig. 3d,e). The gene discussed is LGALS9; the disease is keratoconus.